156 related articles for article (PubMed ID: 19819883)
21. Cannabinoid receptor CB1 antagonists state of the art and challenges.
Bifulco M; Santoro A; Laezza C; Malfitano AM
Vitam Horm; 2009; 81():159-89. PubMed ID: 19647112
[TBL] [Abstract][Full Text] [Related]
22. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
Di Marzo V
Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
[TBL] [Abstract][Full Text] [Related]
23. The endocannabinoid system as a novel approach for managing obesity.
Lillo JL
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S12-20. PubMed ID: 17784530
[TBL] [Abstract][Full Text] [Related]
24. Role of cannabinoid CB2 receptors in glucose homeostasis in rats.
Bermudez-Silva FJ; Sanchez-Vera I; Suárez J; Serrano A; Fuentes E; Juan-Pico P; Nadal A; Rodríguez de Fonseca F
Eur J Pharmacol; 2007 Jun; 565(1-3):207-11. PubMed ID: 17499236
[TBL] [Abstract][Full Text] [Related]
25. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.
Kyrou I; Valsamakis G; Tsigos C
Ann N Y Acad Sci; 2006 Nov; 1083():270-305. PubMed ID: 17148745
[TBL] [Abstract][Full Text] [Related]
26. Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.
Pandey R; Hegde VL; Singh NP; Hofseth L; Singh U; Ray S; Nagarkatti M; Nagarkatti PS
Vitam Horm; 2009; 81():487-504. PubMed ID: 19647124
[TBL] [Abstract][Full Text] [Related]
27. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.
van der Stelt M; Fox SH; Hill M; Crossman AR; Petrosino S; Di Marzo V; Brotchie JM
FASEB J; 2005 Jul; 19(9):1140-2. PubMed ID: 15894565
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity.
Fajardo G; Bernstein D
J Am Coll Cardiol; 2007 Aug; 50(6):537-9. PubMed ID: 17678737
[No Abstract] [Full Text] [Related]
29. Antagonism of type-1 cannabinoid receptors: good for obesity, but is it safe for fertility?
Maccarrone M; Wang H; Dey SK
Clin Endocrinol (Oxf); 2007 Mar; 66(3):456-7. PubMed ID: 17302885
[No Abstract] [Full Text] [Related]
30. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
Hasanein P
Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
[TBL] [Abstract][Full Text] [Related]
32. Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?
Patti ME
J Clin Invest; 2010 Aug; 120(8):2646-8. PubMed ID: 20664166
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid CB1 receptor antagonists for atherosclerosis and cardiometabolic disorders: new hopes, old concerns?
Pacher P
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):7-9. PubMed ID: 19092136
[No Abstract] [Full Text] [Related]
34. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
Sterin-Borda L; Del Zar CF; Borda E
Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
[TBL] [Abstract][Full Text] [Related]
35. The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?
Steffens S; Pacher P
Curr Drug Targets; 2015; 16(4):334-41. PubMed ID: 25469884
[TBL] [Abstract][Full Text] [Related]
36. Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.
Ward SJ; Raffa RB
Obesity (Silver Spring); 2011 Jul; 19(7):1325-34. PubMed ID: 21475141
[No Abstract] [Full Text] [Related]
37. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.
Fakhoury M
Mol Neurobiol; 2017 Jan; 54(1):768-778. PubMed ID: 26768595
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
39. Endocannabinoids and the gastrointestinal tract: what are the key questions?
Sanger GJ
Br J Pharmacol; 2007 Nov; 152(5):663-70. PubMed ID: 17767170
[TBL] [Abstract][Full Text] [Related]
40. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
